Undeterred by domestic regulatory concerns, Hims & Hers is actively executing its global strategy. On December 10, the company launched its comprehensive weight-loss program in the United Kingdom, ...

We tested adult diapers in our labs and got feedback from regular users to find the very best adult diapers and incontinence ...

Hims & Hers Health, Inc. (HIMS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea ...

Novo Nordisk enters the final stretch of 2025 looking almost unrecognizable from the market darling it was just months ago.

Analysts are largely maintaining a "Hold" stance for now. The consensus average price target of $44.90 implies potential upside, but experts appear to be taking a wait-and-see approach. The key ...

Delving into the details, we found 53% of traders were bullish, while 30% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $373,316, and 7 were calls, valued ...

Hims & Hers Health ($HIMS) is strengthening its position in the UK with the launch of weight-loss programs. This launch will ...

Online telehealth company Hims and Hers Health is launching its weight-loss membership and treatment plans in the United ...

The market is projected to reach $110.61 billion by 2030, growing at a 38.6% clip from 2025, as ROI-focused tools displace experimental pilots ( [3]) . With nearly 40% of hospitals now operating at ...

In a dynamic market environment, Hims & Hers Health is making a definitive move to broaden its reach. The telehealth provider has finalized two strategic ...

Hims & Hers Health has sold off ~40% GLP-1 turbulence, but the core growth story remains intact. Read why HIMS stock is a ...